Showing results (201-210 of 6,999) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|July 18, 2023
Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer: An open-label, single-arm, multicenter studyYanjun Xu, Zhiyu Huang, Jianhua Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2023
Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelinesMichael Yan, Alexander V Louie, Rupesh Kotecha, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2023
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trialGuénaëlle Levallet, Fatéméh Dubois, Nicolas Elie, et al.
Lung Cancer (Amsterdam, Netherlands)|July 8, 2023
Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancerH C Donker, K Cuppens, G Froyen, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2023
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancerC Dickhoff, S Unal, D J Heineman, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Smoking status, occupational asbestos exposure and bronchial location of lung cancerChristophe Paris, Jacques Benichou, Florence Saunier, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Fractional allele loss is a valuable marker for human lung cancer detection in sputumDemetrios A Arvanitis, Emmanuel Papadakis, Alexander Zafiropoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Dramatic effect of ZD1839 ('Iressa') in a patient with advanced non-small-cell lung cancer and poor performance statusKeiichi Fujiwara, Katsuyuki Kiura, Hiroshi Ueoka, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathwaysJosé A Sánchez-Alcázar, Dawn A Bradbury, Linhua Pang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancerMark A Socinski, Marcus A Neubauer, Jairo Olivares, et al.
Pageof 700